Concepedia

COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?

Masoud Etemadifar, Nahad Sedaghat, Ali Aghababaee, Parisa K Kargaran, Mohammad Reza Maracy, Mazdak Ganjalıkhani-Hakemi, Milad Rayani, Amir Parsa Abhari, Reza Khorvash, Mehri Salari,

Multiple Sclerosis and Related Disorders · 2021 · 57 citations · 24 references

DOIFull text

Open access

Concepts

References

24

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu, Dingyu Zhang, Xingwang Li et al. · New England Journal of Medicine · 2020 · 30.4K citations · Full text

, , +11

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

Bo Diao, Chenhui Wang, Yingjun Tan et al. · Frontiers in Immunology · 2020 · 2.5K citations · Full text

, , +17

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

Chun Kwok Wong, Charles Lam, Alan Wu et al. · Clinical & Experimental Immunology · 2004 · 1.3K citations · Full text

, , +17

Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies.

Pio Conti · Journal of Biological Regulators and Homeostatic Agents/Journal of Biological Regulators & Homeostatic Agents · 2020 · 1.3K citations

, , +17

Prospective study on the relationship between infections and multiple sclerosis exacerbations

D. Buljevac, H. Zwenneke Flach, Wim C.J. Hop et al. · Brain · 2002 · 429 citations · Full text

, , +15